FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

SAI PARENTERAL'S LTD.

NSE : SAIPARENTBSE : 544742ISIN CODE : INE0H9F01037Industry : Pharmaceuticals & DrugsHouse : Private

BSE406.4014.4 (+3.67 %)

PREV CLOSE (Rs.) 392.00

OPEN PRICE (Rs.) 405.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 548123

TODAY'S LOW / HIGH (Rs.)400.00 416.20

52 WK LOW / HIGH (Rs.)400 416.2

NSE405.7013.7 (+3.49 %)

PREV CLOSE( Rs. ) 392.00

OPEN PRICE (Rs.) 400.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 405.70 (474)

VOLUME 1052029

TODAY'S LOW / HIGH(Rs.) 400.00 416.00

52 WK LOW / HIGH (Rs.)400 416

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

2233.66

Dividend Yield(%)

0.00

TTM EPS (Rs.)

0.00

P/E Ratio

0.00

Book Value (Rs.)

0.00

Face Value (Rs.)

MCap (Rs. in Mn)

17954.44

Price/Earning (TTM)

Price/Sales (TTM)

Price/Book (MRQ)

PAT Margin (%)

ROCE (%)

Incorporation Year : 12-01 2001

Management Info :

Anil Kumar Karusala - Chairman Anil Kumar Karusala - Managing Director

Registered Office :

Address : Plot No.39, 5th Floor, Lavanya Arcade,Jayabheri Enclave, Gachibowli, K. V,Seri Lingampally,
Rangareddy,
Telangana-500032

Phone : 7997991301

Email : cs@saiparenterals.com

Website : www.saiparenterals.com

Registrars Details :

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

02Apr Sai Parenterals debuts at 3% premium o
Sai Parenterals has debuted at Rs 405.00 on the BSE, up by 13 points or..

01Apr New Listing
Notice No. 20260401-40Notice Date 01 Apr 2026Category Company relatedSeg..

19Mar Sai Parenteral's coming with IPO to ra
Sai Parenteral'sSai Parenteral's is coming out with a 100% book building..

Financials

	QTR	ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)

2146.70 (3.09%)

M.Cap (Rs. in Cr)1326.24

Hester Biosciences (BSE)

1427.90 (4.01%)

M.Cap (Rs. in Cr)1214.70

Haleos Labs (BSE)

1299.00 (3.61%)

M.Cap (Rs. in Cr)392.72

RPG Life Sciences (BSE)

1922.95 (2.35%)

M.Cap (Rs. in Cr)3180.37

Shareholding Pattern

	PROMOTERS	51.16%
	NON-INSTITUTION	30.26%
	MUTUAL FUNDS/UTI	3.81%
	FI/BANKS/INSURANCE	2.89%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

SAI PARENTERAL'S LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives